Drawing for UNLOCKING THE FUTURE OF MEDICINE

USPTO serial 86577521

UNLOCKING THE FUTURE OF MEDICINE

Reviewed by CopyMark Law Group

Reg. 4921614Status 710
Filing date
Status date
Registration date
Mar 22, 2016
Examiner
KHAN, AHSEN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with UNLOCKING THE FUTURE OF MEDICINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William M. Bryner

William M. Bryner Kilpatrick Townsend & Stockton LLP1001 West Fourth StreetWinston-Salem, NC 27101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Informatics services, namely, outsourcing services in the nature of arranging service contracts for others; Informatics services, namely, data collection and recording and documenting informed consent processes and protocol compliance in medical, clinical, and clinical trial settings for business purposes; Informatics services, namely, data collection and recording and documenting informed consent processes and protocol compliance in medical, clinical, and clinical trial settings, namely, ambulatory care facilities such as medical offices, clinics, ambulatory surgery facilities, hemodialysis facilities, rehabilitation facilities, drug abuse treatment facilities, family planning centers, hospitals, home health agencies, hospices, clinical trials clinics, oncology clinics, pharmacies, adult day healthcare centers, assisted living facilities, nursing homes, residential health care facilities, disease management programs, wellness management programs for business purposesSECTION 8 - CANCELLED—
042Informatics services for clinical trials and specimen management, namely, providing temporary access to non-downloadable software for database management of informed consent processes and protocol compliance, specimens, tests on specimens and specimen donors in medical, clinical, and clinical trial settings; Informatics services, namely, data collection and recording and documenting informed consent processes and protocol compliance in medical, clinical, and clinical trial settings for medical research and scientific research; Informatics services, namely, data collection and recording and documenting informed consent processes and protocol compliance in medical, clinical, and clinical trial settings, namely, ambulatory care facilities such as medical offices, clinics, ambulatory surgery facilities, hemodialysis facilities, rehabilitation facilities, drug abuse treatment facilities, family planning centers, hospitals, home health agencies, hospices, clinical trials clinics, oncology clinics, pharmacies, adult day healthcare centers, assisted living facilities, nursing homes, residential health care facilities, disease management programs, wellness management programs for medical research and scientific research; Informatics services for tracking and location of stored biological specimens, namely, providing temporary access to non-downloadable software for database management of informed consent processes and protocol compliance, specimens, tests on specimens and specimen donors in medical, clinical, and clinical trial settings; Informatics services for verifying the consented use of biospecimens used in clinical trials and biomedical research, namely, providing temporary access to non-downloadable software for database management of informed consent processes and protocol compliance, specimens, tests on specimens and specimen donors in medical, clinical, and clinical trial settingsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 7, 2022C8..CANCELLED SEC. 8 (6-YR)—
Mar 22, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 28, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 28, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 22, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 21, 2016DOCKASSIGNED TO EXAMINER—
Jan 5, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 5, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 16, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 18, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 18, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Nov 18, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 18, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 18, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 30, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 30, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 30, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 7, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 7, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 7, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2015DOCKASSIGNED TO EXAMINER—
Apr 3, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 30, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance